Bio-Techne Corp
NASDAQ:TECH
Bio-Techne Corp
NASDAQ:TECH
Price:
76.06 USD
-1.59%
Market Closed
Updated:
May 7, 2024
Bio-Techne Corp
Cash from Investing Activities
|
Bio-Techne Corp
Cash from Investing Activities Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio-Techne Corp
NASDAQ:TECH
|
Cash from Investing Activities
-$423.6m
|
CAGR 3-Years
-279%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-13%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Investing Activities
-$377.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-11%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Bio-Techne Corp's Cash from Investing Activities?
Cash from Investing Activities
-423.6m
USD
-423.6m
USD
Based on the financial report for Dec 31, 2023, Bio-Techne Corp's Cash from Investing Activities amounts to -423.6m USD.
What is Bio-Techne Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-13%
-13%
Over the last year, the Cash from Investing Activities growth was -469%. The average annual Cash from Investing Activities growth rates for Bio-Techne Corp have been -279% over the past three years , -6% over the past five years , and -13% over the past ten years .
You don't have any saved screeners yet
